Takenaka Tsuneo, Ozu Choichiro, Oshiba Yoko, Kawakami Yutaka, Okuda Makoto
Nephrology, International University of Health and Welfare, Tokyo, JPN.
Urology, Sanno Hospital, Tokyo, JPN.
Cureus. 2025 Jul 17;17(7):e88150. doi: 10.7759/cureus.88150. eCollection 2025 Jul.
Hepcidin is synthesized in liver and is a master regulator of iron metabolism. Renal anemia was suspected in an 86-year-old man, who was referred to our department. Laboratory tests indicated iron-deficiency anemia (IDA), and ferrous sulphate was initiated. However, no bleeding sites were demonstrated and the response to iron supplementation was not satisfactory. MRI revealed a tumor in the prostate, and prostate biopsy showed poorly differentiated adenocarcinoma that was positive for hepcidin. Anti-androgen therapy ameliorated IDA. Potential roles of hepcidin from prostate cancer (PCa) in the pathogenesis of IDA are discussed in this article.
铁调素在肝脏中合成,是铁代谢的主要调节因子。一名86岁男性被转诊至我科,怀疑患有肾性贫血。实验室检查提示缺铁性贫血(IDA),遂开始使用硫酸亚铁治疗。然而,未发现出血部位,且补铁治疗效果不佳。磁共振成像(MRI)显示前列腺有肿瘤,前列腺活检显示为低分化腺癌,铁调素呈阳性。抗雄激素治疗改善了IDA。本文讨论了前列腺癌(PCa)来源的铁调素在IDA发病机制中的潜在作用。